Navigation Links
Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
Date:4/23/2008

arefully selected portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, Shire's results could be materially affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of pharmaceutical research, product development including, but not limited to the successful development of JUVISTA(R) (Human TGFbeta3) and veleglucerase alfa (GA-GCB); manufacturing and commercialization including, but not limited to, the establishment in the market of VYVANSE(TM) (lisdexamfetamine dimesylate) (Attention Deficit and Hyperactivity Disorder ("ADHD")); the impact of competitive products, including, but not limited to, the impact of those on Shire's ADHD franchise; patents, including but not limited to, legal challenges relating to Shire's ADHD franchise; government regulation and approval, including but not limited to the expected product approval date of INTUNIV(TM) (guanfacine extended release) (ADHD); Shire's ability to secure new products for commercialization and/or development; and other risks and uncertainties detailed from time to time in Shire plc's filings with the Securities and Exchange Commission, including Shire plc's Annual Report on Form 10-K for the year ended December 31, 2007.


'/>"/>
SOURCE Shire PLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Hodgkins Lymphoma
3. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
4. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
5. Knopp Neurosciences Receives Orphan Designation for KNS-760704 for Treatment of ALS
6. Voices to Unite in Los Angeles for 6,000 Children Orphaned Daily
7. Celldex Therapeutics Announces Orphan Drug Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma Multiforme
8. Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy
9. Antheras A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
10. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
11. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009).../ -- Reportlinker.com announces that a new market ..., Pipettes & Pipettors - A Global Market Per...4373/Pipettes--Pipettors---A-Global-Market-Perspec...amp;utm_campaign=prnewswire ,, Pipettes and p...search laboratory. Large-scale applications in lif...
(Date:11/20/2009).../ -- Reportlinker.com announces that a new market ..., Global Markets for Assisted Reproductive Devic...742/Global-Markets-for-Assisted-Reproductive-Devic...pr&utm_campaign=prnewswire ,, Global Mark...Countries in Europe and Japan. This report include...
(Date:11/20/2009)...rstCall/ -- Biotel Inc. (OTC Bulletin Board: BTEL)...tember 30, 2009 with net earnings of $128,000, or .... This compares to net earnings of $328,000, or $...for the first quarter of last year. ,, Commenti...and CEO Steve Springrose said: "Biotel enjoyed str...
Breaking Medicine Technology:Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2Biotel Announced Profitable First Quarter Ended September 30, 2009 2IDEV 28R 29 Technologies Announces First Patient Enrolled in Multi Center Clinical Trial of SUPERA 28R 29 PERipheral Stent 4886 1IDEV 28R 29 Technologies Announces First Patient Enrolled in Multi Center Clinical Trial of SUPERA 28R 29 PERipheral Stent 4886 2Health Robotics Receives Overwhelming Support from its Customers for its McKesson CytoCare Partnership 13664 1Health Robotics Receives Overwhelming Support from its Customers for its McKesson CytoCare Partnership 13664 2Health Robotics Receives Overwhelming Support from its Customers for its McKesson CytoCare Partnership 13664 3Health Robotics Receives Overwhelming Support from its Customers for its McKesson CytoCare Partnership 13664 4Aurora B answers an XIST ential question 9679 1Aurora B answers an XIST ential question 9679 2
...c treatment with chemotherapy and pegylated enzyme...red to chemotherapy alone - - Peg...2 Halozyme Therapeutics,Inc. (Nasdaq: HALO ), a ...lizing products targeting the extracellular matrix...-clinical animal efficacy data,for its pegylated-r...
...o Launch Innovative Laser Lipolysis Technology in ..., WESTFORD, Mass., July 22 Cynosure, Inc.,(Nasda...f a broad array of,light-based aesthetic treatment...artlipo MPX(TM), the company,s high-powered, dual-...d tighten skin through collagen,remodeling. The CE...
Other Medicine Technology:Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 2Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 3
(Date:11/21/2009)... Innovative medical apparel...onference , San Clemente,..., maker of breakthrough medical apparel, today ann...e on display at Medica 2009, a leading internation...seldorf, Germany. Medelita inaugurates its men,s c...
(Date:11/20/2009)..., , Pioneering Neurologist Closer to Understa...Nov. 20 Dr. Jeremy Schm...School and neurologist at the Massachusetts Genera...esented his laboratory,s research on the new field...he MINDlink Foundation. ,, Dr. Schmahmann is an...
(Date:11/20/2009)... Senators and Congressmen i...ble Over their Health Care Vote , ...-- Senators and congressmen running for re-electio...olitical guru Charlie Cook, may come to regret vot...care bill, according to a breaking Zogby Internati...
(Date:11/20/2009)..., , WINSTON-SALEM, N.C., Nov. 20 /PRNewswire-...he is on a mission to redefine what it means to be...sional counselor with a specialty in family counse...Wake Forest University, Gladding says research sho...leads to sadness and even depression during the ho...
(Date:11/20/2009)...Spot blood pressure readings in children with chro...on even during doctor,s office visits increasing...ing to research from Johns Hopkins Children,s Cent...s appears online in the Journal of American Societ...pressure measurements obtained during regular doct...
Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:High blood pressure easy to miss in children with kidney disease 2
...Dirk Brockmann, a theoretical physicist at the Max...on in Gottingen conducted a study which helped the...se by tracking the spread of humans with the help ...an dispersal which would help the scientist fight ...
...Cervical cancer is the second most common cancer n...e of morbidity and mortality. Early recognisation .../and help in cure and reducing mortality due to ce...uld detect early diagnosis. Women above the age of...
...The American Psychological Association (APA) has r...ress as the emphasis is on prevention during the N...percent of Americans fear that stress will have an...er time that help to manage stress in effective wa...
...Mrs. May Murphy from Glasgow was confirmed to have...dose of drugs. Mrs. Murphy was 75 years old and wa... her life very traumatic and she had painful days..... Michael Irwin and Jessica Reid. Mrs. Jessica...
...A large piece of ice is reported to have fallen fr...7 January 2006. This is reported to have taken pla... in the area.// The phenomenon has been dismissed ... The impact is reported to have created a crater w...
...Bio-functional garments like stockings with aloe v...ells like vanilla have been developed as the texti.../ This serves to give the garments an additional f...ould lead to allergic reactions. Various technique...
Other Medicine News:Health News:Tracking the spread of disease with the help of money 2Health News:Scented Garments Hit The Market 2
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: